$BBIO
Price history, market instrument context, member research, and related headlines in one place.
BBIO key statistics
NasdaqGSUSD
52-week range
$52.7535%$93.42
Latest session $65.44–$67.76BridgeBio Pharma, Inc. (BBIO) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $67.13, up $2.19 (3.37%) from the previous close of $64.94. It has traded between $65.44 and $67.76 in the latest session. Over the past year it has ranged from $52.75 to $93.42, leaving it in the lower half of its 52-week range (35%). Reported volume for the session was 2.6M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
KKR reportedly assigned almost 60% of BridgeBio stock sale to five firms — See source for full details.
BridgeBio discloses 5M share secondary offering by KKR affiliate — See source for full details.
Cantor Fitzgerald reiterates BridgeBio stock Overweight rating at $110 — See source for full details.
BridgeBio outlines three launches with first PDUFA set for November 27, 2026 and RECLAIM-HP readout in next 18 months — See source for full details.
Earnings call transcript: BridgeBio beats revenue in Q2 2026 as Attruby surges — See source for full details.
BridgeBio earnings on deck as company eyes four-product future — See source for full details.
Loading $BBIO research…